Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Pacira Biosciences Inc (PCRX)

248 + Investors. Track Smart Money conviction in PCRX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +14
Streak
1Q ▲
Buyers last Q
53%

Smart Money Signals — PCRX

Based on 252 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added PCRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 92% of 3.0Y peak

92% of all-time peak
252 funds currently hold this stock — 92% of the 3.0-year high of 274 funds (reached 2024 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +9% more funds vs a year ago

fund count last 6Q
+21 new funds entered over the past year (+9% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 53% buying

122 buying109 selling
Last quarter: 122 funds bought or added vs 109 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+13 vs last Q)

new funds entering per quarter
Funds opening a new PCRX position: 37 → 48 → 28 → 41. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

66% of holders stayed for 2+ years

■ 66% conviction (2yr+) ■ 18% medium ■ 16% new
166 out of 252 hedge funds have held PCRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📊

Peak discovery — momentum slowing

33 → 37 → 48 → 28 → 41 new funds/Q
New funds entering each quarter: 37 → 48 → 28 → 41. PCRX is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 67% veterans vs 20% newcomers

■ 67% veterans ■ 13% 1-2yr ■ 20% new
Entry-cohort mix of 254 holders: 171 (67%) are 2+ year veterans, 32 entered 1–2 years ago, and 51 (20%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 62% AUM from top-100 funds

62% from top-100 AUM funds
52 of 251 holders are among the 100 largest funds by AUM, controlling 62% of total institutional value in PCRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.0
out of 10
Low Exit Risk
Exit risk score 3.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PCRX

In 2026 Q2, 122 hedge funds were net buyers of PCRX (41 opened a new position, 81 added to an existing one), while 109 reduced or exited (82 trimmed, 27 sold completely) — a 53% buyer ratio, indicating a slight buying edge. 62% of total institutional value in PCRX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +14 funds (more new holders than closures). Total institutional holders: 252.

Hedge Fund Ownership: PCRX

How many hedge funds hold PCRX — quarterly history vs. share price
Quarterly hedge fund ownership of PCRX vs. share price

Market Analysis: PCRX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PCRX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

14 top-rated funds 2 high-conviction
Consensus
5.1
/ 10
breadth
×
Elite
1.7
/ 10
conviction
Hedge Fund Positioning: PCRX
248 + Investors

Track Smart Money conviction in PCRX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 248 238 4.2%
13F Shares 44M 43M 1.11%
Total Value $1.08B $953M 13.29%
New Positions 40 28 +12
Increased Positions 79 90 -11
Closed Positions 29 47 -18
Reduced Positions 82 83 -1
Total Calls 2 1 100.0%
Total Puts 1 1 -
PUT/CALL Ratio 0.5 1.0 Bullish

Statistics: PCRX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

248 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PCRX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 PCRX holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Doma Perpetual Capital Management LLC 16.36% 2,777,794 $70.5M
2 Gagnon Advisors, LLC 5.69% 352,637 $8.9M
3 Gagnon Securities LLC 2.98% 608,617 $15.4M
4 Bridge City Capital, LLC 1.81% 312,297 $7.9M
5 Lion Point Capital, LP 1.64% 13,500 $342K
6 Easterly Investment Partners LLC 0.44% 337,019 $8.6M
7 EntryPoint Capital, LLC 0.27% 14,036 $402K
8 Hillsdale Investment Management Inc. 0.21% 362,700 $9.2M
9 VARCOV Co. 0.21% 21,650 $549K
10 Milestone Asset Management, LLC 0.21% 51,957 $1.3M
11 Bridgeway Capital Management, LLC 0.18% 411,373 $10.4M
12 PDT Partners, LLC 0.18% 132,368 $3.4M
13 Hennion & Walsh Asset Management, Inc. 0.15% 203,520 $5.2M
14 Three Seasons Wealth, LLC 0.15% 62,942 $1.6M
15 Impax Asset Management Group plc 0.12% 750,027 $19.0M
16 Rice Hall James & Associates, LLC 0.12% 93,396 $2.4M
17 Prelude Capital Management, LLC 0.09% 50,635 $1.3M
18 Virtus Advisers, LLC 0.07% 6,935 $176K
19 Martingale Asset Management L P 0.07% 112,025 $2.8M
20 Caitlin John, LLC 0.07% 4,721 $120K
21 Legato Capital Management LLC 0.06% 30,668 $778K
22 Jefferies Financial Group Inc. 0.06% 370,092 $9.4M
23 Renaissance Technologies LLC 0.06% 1,733,801 $44.0M
24 Greenwood Capital Associates LLC 0.05% 21,796 $553K
25 Wedge Capital Management L L P/Nc 0.04% 94,554 $2.4M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Pacira Biosciences Inc (PCRX)

What does the Smart Money Trend signal show for PCRX?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added PCRX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for PCRX?

Slight buying edge — 53% buying: Last quarter: 122 funds bought or added vs 109 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for PCRX holders?

Elite ownership — 62% AUM from top-100 funds: 52 of 251 holders are among the 100 largest funds by AUM, controlling 62% of total institutional value in PCRX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held PCRX?

66% of holders stayed for 2+ years: 166 out of 252 hedge funds have held PCRX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →